Newton, MA, United States of America

Patricia A D'Amore

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Boston, MA (US) (2021)
  • Newton, MA (US) (2016 - 2023)

Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Patricia A D'Amore: Innovator in Ocular Research

Introduction

Patricia A D'Amore is a prominent inventor based in Newton, MA, known for her significant contributions to ocular research. With a total of six patents to her name, she has made remarkable strides in the field of ophthalmology, particularly in understanding and treating conditions related to retinal degeneration.

Latest Patents

Among her latest patents is the invention titled "Endomucin inhibitor as an anti-angiogenic agent." This method focuses on reducing neovascularization in ocular tissue by utilizing an inhibitor of endomucin expression or activity. Another notable patent is "Compounds and compositions for inhibiting retinal pigment epithelium degeneration and methods using the same." This invention provides compounds capable of inhibiting retinal pigment epithelium degeneration or geographic atrophy associated with age-related macular degeneration.

Career Highlights

Patricia has worked with esteemed organizations such as the Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary. Her work in these institutions has been pivotal in advancing research and developing innovative solutions for ocular diseases.

Collaborations

Throughout her career, Patricia has collaborated with notable colleagues, including Magali Saint-Geniez and Cindy Park-Windhol. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Patricia A D'Amore's contributions to ocular research through her patents and collaborations highlight her dedication to improving eye health. Her innovative work continues to impact the field significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…